These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2118117)

  • 41. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.
    Spengler U; Pape GR; Hoffmann RM; Johnson JP; Eisenburg J; Paumgartner G; Riethmüller G
    Hepatology; 1988; 8(3):459-62. PubMed ID: 3371866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.
    Chapman RW; Kelly PM; Heryet A; Jewell DP; Fleming KA
    Gut; 1988 Apr; 29(4):422-7. PubMed ID: 3286382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B.
    Volpes R; van den Oord JJ; Desmet VJ
    Hepatology; 1990 Jul; 12(1):148-54. PubMed ID: 1973679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis.
    Speeti M; Ståhls A; Meri S; Westermarck E
    Vet Immunol Immunopathol; 2003 Nov; 96(1-2):1-12. PubMed ID: 14522129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis.
    Broomé U; Grunewald J; Scheynius A; Olerup O; Hultcrantz R
    J Hepatol; 1997 Mar; 26(3):527-34. PubMed ID: 9075659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases.
    Martins EB; Graham AK; Chapman RW; Fleming KA
    Hepatology; 1996 May; 23(5):988-93. PubMed ID: 8621180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B.
    Paul RG; Roodman ST; Campbell CR; Bodicky CJ; Perrillo RP
    Hepatology; 1991 May; 13(5):820-5. PubMed ID: 2029988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major histocompatibility complex antigens in human liver transplants.
    Steinhoff G
    J Hepatol; 1990 Jul; 11(1):9-15. PubMed ID: 2204660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune hepatitis as a late complication of liver transplantation.
    Hernandez HM; Kovarik P; Whitington PF; Alonso EM
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):131-6. PubMed ID: 11321380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus.
    Imawari M; Nomura M; Kaieda T; Moriyama T; Oshimi K; Nakamura I; Gunji T; Ohnishi S; Ishikawa T; Nakagama H
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2883-7. PubMed ID: 2495538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.
    Ballardini G; Bianchi FB; Mirakian R; Fallani M; Pisi E; Bottazzo GF
    Clin Exp Immunol; 1987 Oct; 70(1):35-46. PubMed ID: 3319302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatocyte-induced CD4
    DeTemple DE; Oldhafer F; Falk CS; Chen-Wacker C; Figueiredo C; Kleine M; Ramackers W; Timrott K; Lehner F; Klempnauer J; Bock M; Vondran FWR
    Liver Transpl; 2018 Mar; 24(3):407-419. PubMed ID: 29365365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line.
    Lobo-Yeo A; McSorley C; McFarlane BM; Mieli-Vergani G; Mowat AP; Vergani D
    Hepatology; 1989 Feb; 9(2):210-4. PubMed ID: 2536348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coexpression of intercellular adhesion molecule-1 and class I major histocompatibility complex antigens on hepatocyte membrane in chronic viral hepatitis.
    Chu CM; Liaw YF
    J Clin Pathol; 1993 Nov; 46(11):1004-8. PubMed ID: 7902850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune disorders of the liver and bile duct.
    Vierling JM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):427-49. PubMed ID: 1512050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of rat hepatocytes in vivo: effect of cholestasis-induced changes in major histocompatibility complex expression.
    Arvieux C; Calmus Y; Gane P; Legendre C; Mariani P; Delelo R; Poupon R; Nordlinger B
    J Hepatol; 1993 Jul; 18(3):335-41. PubMed ID: 8228127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A human T-cell clone cytotoxic for hepatocytes from patients with chronic non-A, non-B hepatitis.
    Imawari M; Nomura M; Kaieda T; Gunji T; Ishikawa T; Nakagama H; Takaku F
    Gastroenterol Jpn; 1990 Sep; 25 Suppl 2():77-81. PubMed ID: 2121578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver disease.
    Freni MA; Ajello A; Resta ML; Gaeta GB; Spadaro A; Fava A; Calapristi I; Alessi N; Ferraù O
    Eur J Clin Invest; 1991 Dec; 21(6):586-91. PubMed ID: 1723384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.
    Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.